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Abstract
Background:  Human T-cell leukemia virus type 1 (HTLV-I) is a human retrovirus that is
etiologically linked to adult T-cell leukemia (ATL), an aggressive and fatal lymphoproliferative
disease. The viral transactivator, Tax, is thought to play an important role during the initial stages
of CD4+ T-cell immortalization by HTLV-1. Tax has been shown to activate transcription through
CREB/ATF and NF-KB, and to alter numerous signaling pathways. These pleiotropic effects of Tax
modify the expression of a wide array of cellular genes. Another viral protein encoded by HTLV-I,
p30, has been shown to affect virus replication at the transcriptional and posttranscriptional levels.
Little is currently known regarding the effect of p30 on the expression and nuclear export of
cellular host mRNA transcripts. Identification of these RNA may reveal new targets and increase
our understanding of HTLV-I pathogenesis. In this study, using primary peripheral blood
mononuclear cells, we report a genome wide analysis of human genes transcriptionally and post-
transcriptionally regulated by the HTLV-I protein p30.
Results: Using microarray analysis, we analyzed total and cytoplasmic cellular mRNA transcript
levels isolated from PBMCs to assess the effect of p30 on cellular RNA transcript expression and
their nuclear export. We report p30-dependent transcription resulting in the 2.5 fold up-regulation
of 15 genes and the down-regulation of 65 human genes. We further tested nuclear export of
cellular mRNA and found that p30 expression also resulted in a 2.5 fold post-transcriptional down-
regulation of 90 genes and the up-regulation of 33 genes.
Conclusion:  Overall, our study describes that expression of the HTLV-I protein p30 both
positively and negatively alters the expression of cellular transcripts. Our study identifies for the
first time the cellular genes for which nuclear export is affected by p30. These results suggest that
p30 may possess a more global function with respect to mRNA transcription and the nuclear
shuttling of cellular mRNA transcripts. In addition, these alterations in gene expression may play a
role in cell transformation and the onset of leukemia.
Background
Human T-cell leukemia virus type 1 (HTLV-I) was identi-
fied in 1980 as the first oncogenic human retrovirus.
Infection is associated with adult T-cell leukemia (ATL) as
well as other pathological disorders such as tropical spas-
tic paraparesis/HTLV-1 associated myelopathy (TSP/
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HAM) [1-3]. It is estimated that 25 million people world-
wide are infected with HTLV-I. HTLV-I is endemic in
Japan, the Caribbean, South America and Central Africa.
The majority of carriers will remain asymptomatic
throughout their entire lives, and data from Japan has esti-
mated that approximately 6.6% of infected males and
2.1% of infected females will ultimately develop ATL dur-
ing their lifespan [4]. HTLV-I is transmitted vertically from
mother to child prior to birth or through contaminated
blood products. Intriguingly, individuals infected with
HTLV-1 later in life rarely present with ATL, suggesting
that infection during infancy is an important factor for the
development of ATL.
HTLV-I is a relatively small virus with a genome only 9 kb
in size that encodes for the classic retroviral structural pro-
teins gag, pol, and env. Downstream of the env gene lies a
unique region, named pX, which encodes for a number of
non-structural proteins involved in virus gene expression
and cell transformation, including Tax, Rex, p30, p12,
p13, and HBZ. Replication of HTLV-I is dependent on the
expression of the viral transactivating protein, Tax, which
recruits CREB, CBP/p300 and PCAF, to activate viral gene
transcription from the viral LTR [5-11]. As Tax has been
implicated in the activation of a number of cell survival
pathways, it is believed to be primarily responsible for
facilitating cell transformation and the onset of leukemia.
Tax, however, is highly immunogenic and cells expressing
high amounts of Tax are readily detected and cleared by
the human immune system. As a result, cells that express
low amounts of Tax are preferentially selected in vivo; in
fact, ATL cells from leukemic patients do not express
detectable viral proteins. This selective mechanism is
apparent as patients who develop ATL exhibit a clonal pat-
tern of provirus integration and T-cell receptor rearrange-
ment, indicating that ATL arises from a single infected
progenitor cell.
Other HTLV-I non-structural proteins appear to regulate
various steps of virus gene expression, often through
unique mechanisms. Rex is an RNA binding protein that
binds to an RNA responsive element located at the 3' ter-
minus of all viral mRNA molecules to facilitate RNA
export to the cytoplasm [12-14]. In contrast to Tax and
Rex which positively regulate virus gene expression, two
other viral proteins have been shown to negatively regu-
late gene expression. HBZ, the HTLV basic leucine zipper
protein, is an anti-sense-encoded protein that interferes
with Tax-mediated viral gene expression [15,16]. Another
intriguing viral protein, p30, is a post-transcriptional
repressor of gene expression [17,18]. Specifically, p30
expression inhibits the export of the tax/rex mRNA mes-
sage from the nucleus [17]. Unlike Rex, p30 does not shut-
tle between the nucleus and the cytoplasm and is
predominantly localized to the nucleus/nucleolus, con-
sistent with a nuclear RNA retention mechanism and
function [19]. p30 interacts with Rex, and this interaction
is enhanced in the presence of viral RNA, suggesting that
p30 may function by binding Rex in complex with viral
RNA, thereby inhibiting Rex-dependent RNA export [20].
It is not known, however, whether this interaction is
required for the ability of p30 to inhibit Tax mRNA export
from the nucleus.
Recently, it has been shown that p30 expression also
influences the cell cycle and TLR signalling [21,22]. A sep-
arate gene profile experiment suggested that p30 was able
to specifically down-regulate a variety of cellular genes
involved in apoptosis, cell cycle, and transcription [23].
Whether these effects are required for HTLV-I infectivity or
cell transformation remains to be seen, although studies
have shown that p30 expression is required for efficient
virus replication and persistence in vivo [24,25].
While some information is known regarding the effects of
p30 on gene transcription, the effects of p30 on cellular
mRNA nuclear export have not been investigated. Using
differential gene microarray analysis on total and cyto-
plasmic RNA extracts from peripheral blood mononuclear
cells expressing p30 in comparison with mock-transduced
cells, we assessed the relative abundance of cellular tran-
scripts regulated at both the transcriptional and post tran-
scriptional level. We found that p30 alters the expression
and nucleo-cytoplasmic localization of a number of cellu-
lar transcripts involved in RNA processing, cell signalling,
metabolism, and cell division. These results will help pave
the way for future studies aimed at understanding the role
of these cellular RNA in HTLV-I pathogenesis.
Results
p30 transcriptionally regulates the expression level of 
various cellular mRNAs
To analyze the transcriptional effects of p30 on global
gene expression, we isolated RNA from total RNA pools
following p30 expression in PBMCs using a lentiviral sys-
tem. Cells were co-transfected with a packaging vector
pDNL6, VSV-G to pseudotype lentiviral particles, and
either empty vector pHR'CMV, or pHR'CMV:myc-p30. To
ensure equivalent virus production from cells transfected
with either pHR'CMV or pHR'CMV:myc-p30, we assessed
the amount of lentiviral particles released into the super-
natant by analyzing supernatants for HIV p24 Gag, which
is a structural protein packaged as part of the lentiviral
particle. Cell supernatants following transfection were
harvested, lysed in SDS sample buffer and separated by
SDS-PAGE. Western blotting with anti-p24 showed an
equivalent amount of p24 in the supernatants of cells
transfected with either the control plasmid pHR'CMV or
pHR'CMV:myc-p30 (Figure 1A). We also assessed the
expression of p30 by staining lentivirus-infected cells withBMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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Production of infectious lentiviral particles from transfected 293 T cells Figure 1
Production of infectious lentiviral particles from transfected 293 T cells. A) 293 T cells were mock transfected, or 
transfected with pDNL6, pVSV-G, and either pHR'CMV or pHR'CMV:myc-p30, and supernatants were western blotted for 
HIV p24 Gag expression. B) Lymphocytes co-cultured with 293 T producer cells transfected with either pHR'CMV or 
pHR'CMV:myc-p30 were harvested, fixed and stained with anti-myc (9E10) and anti-mouse-Alexa488, and visualized by immun-
ofluorescence. C) Lymphocytes co-cultured with 293 T cells transfected with either pHR'CMV or pHR'CMV:GFP were fixed 
and analyzed for GFP expression by flow cytometry. D) Cytosolic or nuclear protein fractions were isolated following cyto-
plasmic RNA extraction, and were analyzed by western blotting with either anti-cyclin A or anti-Bax to assess nuclear and 
cytoplasmic fraction purity, respectively.BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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anti-myc to detect p30 by immunofluorescence. As
expected, nucleolar p30 was observed, indicating that p30
was expressed following infection of co-cultured cells
(Figure 1B). To determine the percentage of cells infected
using our lentiviral packaging and infection system, we
co-transfected cells with pHR'CMV:GFP, which expresses
GFP. Following lentiviral infection, greater than 85% of
cells expressed GFP, indicating that our lentiviral packag-
ing system is highly effective (Figure 1C).
To examine RNA transcript levels in PBMCs in the pres-
ence and absence of p30, lentivirus-producing 293 T cells
were co-cultured with peripheral blood mononuclear cells
for 48 hours, total RNA was isolated and RNA samples
were subjected to microarray analysis. Following microar-
ray analysis, data sets were analyzed using the following
steps: transcripts significantly present in the total RNA
fraction from cells transduced with pHR'CMV lacking p30
were first selected. This data set was then sorted based on
a decrease in transcript abundance following expression
of p30. Sixty-five probes exhibited a decrease of greater
than 2.5 fold and were deemed to be down-regulated in
the presence of p30 (Table 1), and an additional 678 were
down-regulated more than 1.5 fold (see Additional file 1).
These genes were found to belong to several categories,
such as cell signalling, transcription/translation, cell cycle,
and metabolism.
Among the genes down-regulated by p30 was the gene
encoding anti-apoptotic Bcl-2, which is noteworthy since
HTLV-1-infected cells are highly resistant to apoptosis.
Bcl-2 levels, however, are not known to be elevated in
HTLV-infected cells, as other anti-apoptotic proteins
appear to be involved in protecting cells from apoptosis
[26-28]. Another apoptosis-related gene that was down-
regulated, programmed cell death-4 (PDCD4) [29],
inhibits protein synthesis by suppression of translation
initiation by targeting eIF-4A. In addition, loss of PDCD4
expression in human lung cancer cells has been shown to
correlate with tumor progression and poor prognosis[30].
We also found that p30 down-regulates expression of
Presenilin 1, a critical component of the gamma-secretase
complex, which has been documented to be involved in
Notch signalling [31]. Decreased expression of Presenilin
1 is associated with resistance of acute T-cell lymphoblas-
tic leukemia (ALL) to gamma-secretase inhibitors (GSI).
We have previously reported that p30 nucleolar retention
is in part due to its association with the 60S ribosomal
large subunit component L23A. The present study also
reveals that expression of several ribosomal proteins is
reduced upon p30 expression, including mitochondrial
ribosomal protein L38, similar to ribosomal protein L36,
and ribosomal protein L21. Rab guanine nucleotide
exchange factor (GEF) and the binding partner of phos-
phatidyl inositol 4-kinase (PI4K) were both down-regu-
lated by p30. Although there is no information known on
HTLV-I and PI4K, HTLV infected cells have constitutive
activation of PI3K [32,33]. We also observed a decrease in
the expression of a number of zinc finger proteins, which
are also commonly down-regulated in ATL samples [34].
We next assessed whether p30 expression resulted in the
transcriptional up-regulation of any cellular transcripts.
Data sets from the above samples were instead selected
based on the presence of a particular transcript in the total
RNA of p30-expressing cells. This data was then sorted
based on an increase in transcript abundance following
p30 expression as compared to samples transduced with
the pHR'CMV lentivirus alone. Those probes exhibiting
greater than a 2.5 fold change in abundance in the pres-
ence of p30 were deemed to be up-regulated. Interest-
ingly, only 15 genes were up-regulated, with the largest
group of genes being those involved in transcription/
translation and RNA processing (Table 2). One of these
genes, FOXC2, has been implicated in angiogenesis and
cell migration [35]. While very few genes were seen to be
up-regulated more than 2.5 fold, close to 500 genes were
up-regulated between 1.5 and 2.5 fold (see Additional file
2). Interestingly, several of these genes identified are also
known to be up-regulated in acute ATL, including a 90
kDa heat-shock protein, RNA polymerase II (DNA
directed), regulator of G-protein signalling, [34], and gen-
eral transcription factor IIH [36]. Of note, RAG-1 is up-
regulated in our p30 extracts, but is conversely seen down-
regulated in Tax microarray analysis [37], while Bcl-3, up-
regulated in our screen (Table 2), is also up-regulated by
Tax [37].
p30 post-transcriptionally regulates the levels of certain 
cellular mRNA transcripts
It has been demonstrated that p30 specifically inhibits the
export of tax/rex mRNA molecules from the nucleus by an
unknown mechanism [17]. Although tax/rex mRNA is the
only known transcript which is retained in the nucleus by
p30, we hypothesized that other cellular transcripts might
also be subject to this virus-mediated RNA retention
mechanism. To investigate whether the export of any cel-
lular RNA transcripts from the nucleus to the cytoplasm
was inhibited by p30, we isolated RNA from the cytoplas-
mic fraction of cells in parallel with our total RNA extrac-
tions described above. To ascertain the relative purity of
cytoplasmic fractions, proteins were isolated following
RNA extraction and analyzed by western blotting for
known nuclear and cytoplasmic proteins, Cyclin A and
Bax, respectively [38,39]. The cytoplasmic fraction was rel-
atively free of cyclin A, while the nuclear fraction was cor-
respondingly free of cytoplasmic Bax protein, as expected
(Figure 1D).
Extracted RNA samples were then subjected to microarray
analysis. To identify those transcripts that p30 might
inhibit the export of, we first selected transcripts that wereBMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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Table 1: Genes down-regulated in the total RNA fraction in the presence of HTLV-I p30
Probe ID Gene Description Gene Fold Change
Transcription/Translation/RNA Processing
1554468_s_at Mitochondrial Ribosomal Protein L38 FBF1 0.11
217340_at Ribosomal Protein L21 RPL21 0.16
231658_x_at Similar to Ribosomal Protein L36 LOC127295 0.19
243560_at Heat Shock Transcription Factor 1 HSF1 0.24
216282_x_at Polymerase (RNA) II (DNA Directed) Polypeptide C, 33 kda POLR2C 0.25
236522_at Nuclear Factor I/A NFIA 0.27
1553181_at DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 31 DDX31 0.27
216117_at Exosome Component 2 EXOSC2 0.32
208345_s_at Pou Domain, Class 3, Transcription Factor 1 POU3F1 0.37
1552499_a_at Zinc Finger Protein 31 (Kox 29) ZSCAN20 0.38
Metabolism
1569631_at Nicotinamide Nucleotide Adenylyltransferase 1 NMNAT1 0.05
217203_at Glutamate-Ammonia Ligase (Glutamine Synthetase) GLUL 0.09
226209_at NADH Dehydrogenase (Ubiquinone) Flavoprotein 3, 10 kda NDUFV3 0.16
239333_x_at Glutathione S-Transferase Subunit 13 Homolog GSTK1 0.31
226947_at Glucuronidase, Beta-Like 2 GUSBL2 0.34
213935_at Abhydrolase Domain Containing 5 ABHD5 0.35
238724_at 2,3-Bisphosphoglycerate Mutase BPGM 0.37
213582_at ATPase, Class VI, Type 11a ATP11A 0.38
236018_at Adenosine Deaminase-Like ADAL 0.40
Signal Transduction
1555340_x_at Rap1a, Member Of Ras Oncogene Family RAP1A 0.00
218711_s_at Serum Deprivation Response (Phosphatidylserine Binding Protein) SDPR 0.05
210374_x_at Prostaglandin E Receptor 3 (Subtype Ep3) PTGER3 0.12
216979_at Nuclear Receptor Subfamily 4, Group A, Member 3 NR4A3 0.13
242875_at Presenilin 1 (Alzheimer Disease 3) PSEN1 0.13
204936_at Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 MAP4K2 0.25
211471_s_at Rab36, Member Ras Oncogene Family RAB36 0.28
215134_at Phosphatidylinositol 4-Kinase Type Ii PI4K2A 0.33
219738_s_at Protocadherin 9 PCDH9 0.35
239202_at Rab3b, Member Ras Oncogene Family RAB3B 0.36
205280_at Glycine Receptor, Beta GLRB 0.37
209101_at Connective Tissue Growth Factor CTGF 0.37
Cell Division/Cell Cycle
227578_at Thymopoietin TMPO 0.15
219831_at Cyclin-Dependent Kinase-Like 3 CDKL3 0.29
Cytoskeleton
239067_s_at Pannexin 2 PANX2 0.16
206117_at Tropomyosin 1 (Alpha) TPM1 0.31
205328_at Claudin 10 CLDN10 0.33
Transport
216504_s_at Solute Carrier Family 39 (Zinc Transporter), Member 8 SLC39A8 0.11
242554_at Two Pore Segment Channel 2 TPCN2 0.40
Apoptosis
202730_s_at Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) PDCD4 0.34
211603_s_at Ets Variant Gene 4 (E1A Enhancer Binding Protein, E1af) ETV4 0.34
244035_at B-Cell Cll/Lymphoma 2 BCL2 0.36
Ubiquitin
241900_at Smad Specific E3 Ubiquitin Protein Ligase 2 SMURF2 0.20
243216_x_at Ubiquitin Specific Peptidase 40 USP40 0.38
Other/Unknown
233351_at DNAI (Hsp40) Homolog, Subfamily C, Member 3 DNAJC3 0.08
243221_at Family With Sequence Similarity 20, Member A FAM20A 0.08
236378_at Calcium And Integrin Binding Family Member 4 CIB4 0.09
222109_at Guanine Nucleotide Binding Protein-Like 3 (Nucleolar)-Like GNL3L 0.09
243989_at Ku-Mel-3 Protein KU-MEL-3 0.13
221225_at Dephospho-Coa Kinase Domain Containing DCAKD 0.13
229678_at Male-Enhanced Antigen 1 MEA1 0.15BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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present in equal abundance in total RNA fractions from
cells either plus or minus p30. The data were then re-
sorted based on the relative decrease in abundance of
transcripts in the cytoplasmic fraction in the presence of
p30. By ensuring that transcripts were present in the total
RNA fraction in both the presence and absence of p30,
any difference seen in cytoplasmic abundance of a partic-
ular transcript would not be the result of a general inhibi-
tion of transcription by p30. This parallels the repression
of Tax mRNA export, where Tax mRNA is decreased in
cytoplasmic RNA fractions in the presence of p30, but
total Tax mRNA levels are unchanged [17]. In our screen,
90 transcripts were decreased by more than 2.5 fold (Table
3), and another 650 transcripts showed a decreased cyto-
plasmic abundance of more than 1.5 fold in the presence
of p30 (see Additional file 3). Classes of transcripts exhib-
iting lower abundance in the cytoplasm in the presence of
p30 include genes involved in transcription/translation,
cell signalling, the cytoskeleton, DNA repair and replica-
tion, and metabolism.
Of the genes we identified, those of particular interest
with respect to HTLV and the onset of leukemia include
MDM4, a known regulator of p53 [40], and the single-
stranded nucleic acid binding protein RBMS1, which has
also been linked to transcription and apoptosis [41]. We
also found that histone deacetylase HDAC3 was repressed
by p30. HDAC3 is known to form multi-protein com-
plexes with the co-repressors SMRT and N-CoR and regu-
lates the transcription of numerous genes [42,43]. In
addition, HDAC3 has multiple functions that relate to
HTLV-I infected cells. HDAC3 regulates the duration of
1552430_at WD Repeat Domain 17 WDR17 0.24
211113_s_at ATP-Binding Cassette, Sub-Family G (White), Member 1 ABCG1 0.28
207408_at Solute Carrier Family 22 (Organic Cation Transporter), Member 14 SLC22A14 0.30
233532_x_at Intraflagellar Transport 52 Homolog (Chlamydomonas) IFT52 0.34
214181_x_at Leukocyte-Specific Transcript 1 LST1 0.35
203404_at Armadillo Repeat Containing, X-Linked 2 ARMCX2 0.36
203765_at Grancalcin, Ef-Hand Calcium Binding Protein GCA 0.36
1555046_at FSH Primary Response (Lrpr1 Homolog, Rat) 1 CENPI 0.37
235991_at CUB Domain Containing Protein 2 CDCP2 0.37
1554112_a_at Unc-51-Like Kinase 2 (C. Elegans) ULK2 0.37
235349_at Family With Sequence Similarity 82, Member A FAM82A 0.38
206928_at Zinc Finger Protein 124 (Hzf-16) ZNF124 0.39
236943_at Lymphocyte Antigen 86 LY86 0.39
242996_at Mitochondrial Translational Release Factor 1 MTRF1 0.40
Table 1: Genes down-regulated in the total RNA fraction in the presence of HTLV-I p30 (Continued)
Table 2: Genes up-regulated in the total RNA fraction in the presence of HTLV-I p30
Probe ID Gene Description Gene Fold Change
Transcription/Translation/RNA Processing
224442_AT PHD Finger Protein 6 PHF6 3.2
219730_AT Mediator Of RNA Polymerase II Transcription, Subunit 18 Homolog (Yeast) MED18 2.7
1560981_A_AT Peroxisome Proliferative Activated Receptor, Alpha PPARA 2.6
239058_AT Forkhead Box C2 (Mfh-1, Mesenchyme Forkhead 1) FOXC2 2.6
Metabolism
210050_AT Triosephosphate Isomerase 1 TPI1 3.6
224042_AT Ureidopropionase, Beta UPB1 2.6
Transport
243166_AT Solute Carrier Family 30 (Zinc Transporter), Member 5 SLC30A5 3.0
Cell Adhesion
227209_AT Contactin 1 CNTN1 2.5
Ubiquitin/Protein Degradation
1569706_AT Myb-Like, Swirm And Mpn Domains 1 MYSM1 2.9
203758_AT Cathepsin O CTSO 2.6
Other/Unknown
228493_AT A Kinase (Prka) Anchor Protein 14 AKAP14 4.3
1559048_AT Bah Domain And Coiled-Coil Containing 1 BAHCC1 2.6
226489_AT Transmembrane And Coiled-Coil Domain Family 3 TMCC3 2.6
1554237_AT Serologically Defined Colon Cancer Antigen 8 SDCCAG8 2.5
227546_X_AT Aurora Kinase A Interacting Protein 1 AURKAIP1 2.5BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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Table 3: Genes down-regulated in the cytoplasm in the presence of HTLV-I p30
Probe ID Gene Description Gene Fold Change
Transcription/Translation/RNA Processing
209060_X_AT Nuclear Receptor Coactivator 3 NCOA3 0.11
242113_AT A Kinase (Prka) Anchor Protein 8-Like AKAP8L 0.11
228711_AT Zinc Finger Protein 37a (Kox 21) ZNF37A 0.14
238185_AT RNA Binding Motif, Single Stranded Interacting Protein 1 RBMS1 0.20
223409_AT Forkhead Box K2 FOXK2 0.23
1557813_AT Single-Stranded DNA Binding Protein 2 SSBP2 0.29
213837_AT Lethal (3) Malignant Brain Tumor L(3)Mbt Protein (Drosophila) Homolog L3MBTL 0.31
240482_AT Histone Deacetylase 3 HDAC3 0.32
203674_AT Helicase With Zinc Finger HELZ 0.37
242407_AT Arginine-Glutamic Acid Dipeptide (Re) Repeats RERE 0.38
212720_AT Poly(A) Polymerase Alpha PAPOLA 0.38
1562741_AT Ubx Domain Containing 2 UBXD2 0.39
213756_S_AT Heat Shock Transcription Factor 1 HSF1 0.40
Metabolism
213935_AT Abhydrolase Domain Containing 5 ABHD5 0.04
237849_AT Mannosidase, Alpha, Class 1a, Member 1 MAN1A1 0.17
208917_X_AT NAD Kinase NADK 0.24
1570165_AT Carbohydrate (Chondroitin 4) Sulfotransferase 11 CHST11 0.33
238114_AT Protein-L-Isoaspartate (D-Aspartate) O-Methyltransferase Domain Containing 1 PCMTD1 0.34
236742_AT ADP-Ribosylation Factor Guanine Nucleotide-Exchange Factor 1(Brefeldin A-Inhibited) ARFGEF1 0.35
210963_S_AT Glycogenin 2 GYG2 0.36
223142_S_AT Uridine-Cytidine Kinase 1 UCK1 0.37
243501_AT ATP Synthase, H+ Transporting, Mitochondrial F0 Complex, Subunit B1 ATP5F1 0.37
207904_S_AT Leucyl/Cystinyl Aminopeptidase LNPEP 0.38
203180_AT Aldehyde Dehydrogenase 1 Family, Member A3 ALDH1A3 0.40
Cell Signaling/Immune System
234628_AT Rab28, Member Ras Oncogene Family RAB28 0.11
201295_S_AT WD Repeat And Socs Box-Containing 1 WSB1 0.18
235213_AT Inositol 1,4,5-Trisphosphate 3-Kinase B ITPKB 0.19
229895_S_AT Nck Adaptor Protein 1 NCK1 0.25
223674_S_AT CDC42 Small Effector 1 CDC42SE1 0.28
205988_AT CD84 Antigen (Leukocyte Antigen) CD84 0.28
242946_AT CD53 Antigen CD53 0.30
226375_AT Lemur Tyrosine Kinase 2 LMTK2 0.32
203854_AT Complement Factor I CFI 0.36
1569022_A_AT Phosphoinositide-3-Kinase, Class 2, Alpha Polypeptide PIK3C2A 0.37
204813_AT Mitogen-Activated Protein Kinase 10 MAPK10 0.38
235419_AT Erbb Receptor Feedback Inhibitor 1 ERRFI1 0.39
Cell Division/DNA Replication & Repair
229548_AT Unc-84 Homolog B (C. Elegans) UNC84B 0.07
1557830_AT Cyclin J CCNJ 0.28
Cytoskeleton
211089_S_AT Nima (Never In Mitosis Gene A)-Related Kinase 3 NEK3 0.13
243988_AT Tubulin Tyrosine Ligase-Like Family, Member 5 TTLL5 0.14
240363_AT Ankyrin 1, Erythrocytic ANK1 0.16
217297_S_AT Myosin IXb MYO9B 0.18
1565149_AT Dynein, Cytoplasmic 2, Heavy Chain 1 DYNC2H1 0.31
236437_AT Laminin, Beta 1 LAMB1 0.34
239170_AT Arp3 Actin-Related Protein 3 Homolog (Yeast) ACTR3 0.37
215910_S_AT Fibronectin Type III Domain Containing 3a FNDC3A 0.38
Transport
1553148_A_AT Sorting Nexin 13 SNX13 0.12
233420_AT Nucleoporin 133 kda NUP133 0.27
207594_S_AT Synaptojanin 1 SYNJ1 0.30
203106_S_AT Vacuolar Protein Sorting 41 (Yeast) VPS41 0.31
212921_AT Set And Mynd Domain Containing 2 SMYD2 0.35
1559862_AT Coatomer Protein Complex, Subunit Alpha COPA 0.37
244219_AT Wilms Tumor 1 Associated Protein WTAP 0.39BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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NF-kB activation by deacetylation of RelA thereby pro-
moting its interaction with inhibitory-kB (IkB) and termi-
nation of NF-kB signalling [44]. HDAC3 has also been
found to deacetylate acetyltransferases PCAF and p300/
CBP and inhibit their function [45,46]. Since both PCAF
and p300/CBP are required for Tax-mediated viral tran-
scription, it makes sense that p30 would block this path-
way. Finally, downregulation of HDAC3 below threshold
induces G2/M arrest, a phenotype previously observed in
cells overexpressing p30 [21,47]. These observations war-
rant further studies. Our results also indicate a decreased
expression of Nup133, a nucleoporin protein involved in
mRNA export [48]. This is of particular interest because of
our previous work demonstrating a nuclear retention of
tax/rex mRNA by p30 that is currently under investigation
[17].
We then re-sorted the data to examine whether any genes
showed an increased abundance in the cytoplasm in the
presence of p30. Intriguingly, despite the role of p30 as an
inhibitor of Tax mRNA export, we observed 33 genes that
showed an increased abundance of more than 2.5 fold in
the cytoplasm in the presence of p30 (Table 4), and
another 930 genes increased in the cytoplasm more than
1.5 fold (see Additional file 4). These probes were present
in equal quantities in the total RNA fractions, indicating
that their increased abundance in the cytoplasm was not
due to an altered expression pattern at the transcriptional
level. Of particular interest are groups of genes involved in
DNA replication and repair, apoptosis, cell adhesion, and
cell signalling, all of which are known classes of genes to
be intimately linked with the onset of cancer. Again, none
of the genes identified in our screen were previously
shown to be significantly altered in ATL cells [34]. Upreg-
ulated genes include two Rab GTPases, which are believed
to play a role in oncogenesis [49], and CCAR1, which is
involved in gene expression and functions as a p53 coac-
tivator [50]. Other genes observed to be increased
Apoptosis
1562111_AT Brain And Reproductive Organ-Expressed (Tnfrsf1a Modulator) BRE 0.01
241876_AT MDM4, Transformed 3T3 Cell Double Minute 4, p53 Binding Protein MDM4 0.27
Other/Unknown
227425_AT Ralbp1 Associated Eps Domain Containing 2 REPS2 0.06
244571_S_AT Tetratricopeptide Repeat Domain 12 TTC12 0.08
242870_AT Family With Sequence Similarity 80, Member B FAM80B 0.10
222566_AT Suppressor Of Variegation 4–20 Homolog 1 (Drosophila) SUV420H1 0.10
240149_AT Amplified In Breast Cancer 1 HEATR6 0.11
232304_AT Pellino Homolog 1 (Drosophila) PELI1 0.13
238995_AT Sulfotransferase Family, Cytosolic, 1a, Phenol-Preferring, Member 1 SULT1A1 0.18
231437_AT Solute Carrier Family 35, Member D2 SLC35D2 0.19
242662_AT Proprotein Convertase Subtilisin/Kexin Type 6 PCSK6 0.20
1557394_AT Discs, Large (Drosophila) Homolog-Associated Protein 4 DLGAP4 0.20
238011_AT Pro0149 Protein C16ORF72 0.20
241268_X_AT SAM Domain And HD Domain 1 SAMHD1 0.21
222038_S_AT WD Repeat Domain 50 UTP18 0.22
231003_AT Solute Carrier Family 35, Member B3 SLC35B3 0.22
242268_AT Cug Triplet Repeat, RNA Binding Protein 2 CUGBP2 0.26
202516_S_AT Discs, Large Homolog 1 (Drosophila) DLG1 0.26
1556839_S_AT Spectrin, Beta, Non-Erythrocytic 5 SPTBN5 0.27
221430_S_AT Ring Finger Protein 146 RNF146 0.28
1558941_AT Zinc Finger Protein 704 ZNF704 0.29
211392_S_AT Zinc Finger Protein 278 PATZ1 0.29
216604_S_AT Solute Carrier Family 7 (Cationic Amino Acid Transporter, Y+ System), Member 8 SLC7A8 0.29
240125_AT Dystrobrevin, Alpha DTNA 0.30
207781_S_AT Zinc Finger Protein 6 (Cmpx1) ZNF711 0.30
1559078_AT B-Cell Cll/Lymphoma 11a (Zinc Finger Protein) BCL11A 0.31
237747_AT Family With Sequence Similarity 107, Member B FAM107B 0.32
1570165_AT Carbohydrate (Chondroitin 4) Sulfotransferase 11 CHST11 0.33
219846_AT Gon-4-Like (C.Elegans) GON4L 0.36
209766_AT Peroxiredoxin 3 PRDX3 0.37
1556538_AT Antigen P97 (Melanoma Associated) Identified By Monoclonal Antibodies 133.2 And 96.5 MFI2 0.37
243367_AT Dopamine Receptor D5 Pseudogene 2 DRD5P2 0.37
1552678_A_AT Ubiquitin Specific Peptidase 28 USP28 0.38
236603_AT WD Repeat Domain 32 WDR32 0.38
224703_AT WD Repeat Domain 22 WDR22 0.39
232362_AT Coiled-Coil Domain Containing 18 CCDC18 0.40
213748_AT Tripartite Motif-Containing 66 TRIM66 0.40
Table 3: Genes down-regulated in the cytoplasm in the presence of HTLV-I p30 (Continued)BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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between 1.5 and 2.5 fold include XRCC1 binding protein-
1, which parallels a previous observation describing an
increase in abundance of XRCC1 DNA repair gene in ATL
cells [36]. We also observed granzyme B and perforin to
be up-regulated in the cytoplasm of p30-expressing cells,
contrasting a decrease in the expression of granzyme A in
ATL cells [34]. Whether these cytotoxic molecules are
involved in the pathogenesis or development of disease in
HTLV-I-infected T-cells remains to be investigated.
Discussion
The regulation of viral and cellular transcripts is of great
importance, particularly with respect to latent viruses that
persist in the human host for extended periods of time. In
the case of adult T-cell leukemia, leukemic cells are
infected with HTLV-I and contain the proviral genome,
but there is extremely little expression of viral transcripts.
Despite being a non-structural protein that localizes to the
nucleolus, the HTLV-I accessory protein p30 is required
for efficient infection in vivo [19,24]. Recent studies by
our group and others have since shown that p30 acts as a
negative regulator of virus expression by inhibiting the
nuclear export of tax/rex mRNA [17,18]. Additional stud-
ies have reported that p30 is a transcriptional inhibitor of
the viral LTR. In addition to regulating the export of tax/
rex mRNA to the cytoplasm, p30 expression modifies a
number of signalling pathways such as TLR4, CREB, and
GSK3β [22,51,52]. How p30 accomplishes these changes
Table 4: Genes up-regulated in the cytoplasm in the presence of HTLV-I p30
Probe ID Gene Description Gene Fold Change
Transcription/Translation
236566_AT Cell Division Cycle And Apoptosis Regulator 1 CCAR1 2.8
230998_AT Chromobox Homolog 3 (Hp1 Gamma Homolog, Drosophila) CBX3 2.7
236244_AT Heterogeneous Nuclear Ribonucleoprotein U (Scaffold Attachment Factor A) HNRNPU 2.6
Metabolism
233445_AT Bub1 Budding uninhibited by Benzimidazoles 1 Homolog (Yeast) BUB1 2.5
221139_S_AT Cysteine Sulfinic Acid Decarboxylase CSAD 2.7
204646_AT Dihydropyrimidine Dehydrogenase DPYD 3.2
242235_X_AT Nardilysin (N-Arginine Dibasic Convertase) NRD1 2.6
229465_S_AT Protein Tyrosine Phosphatase, Receptor Type, D PTPRS 2.7
242905_AT Putatative 28 KDa Protein PNO1 3.1
38964_R_AT Wiskott-Aldrich Syndrome (Eczema-Thrombocytopenia) WAS 2.6
Signal Transduction
1552312_A_AT Microfibrillar-Associated Protein 3 MFAP3 2.5
220500_S_AT Rab, Member of Ras Oncogene Family-Like 2a RABL2A 4.1
220500_S_AT Rab, Member of Ras Oncogene Family-Like 2b RABL2B 4.1
239031_AT Somatostatin Receptor 2 SSTR2 2.9
Cell Division/DNA Replication
234605_AT CDC14 Cell Division Cycle 14 Homolog B (S. Cerevisiae) CDC14B 3.0
1566043_AT Inner Centromere Protein Antigens 135/155 kda INCENP 2.9
228670_AT Telomerase-Associated Protein 1 TEP1 2.5
Transport
1558028_X_AT Translocation Associated Membrane Protein 1 TRAM1 2.7
Development
224368_S_AT Ndrg Family Member 3 NDRG3 2.5
217107_AT Ribosomal Protein S4, X-Linked RPS4X 2.6
232975_AT Tripartite Motif-Containing 26 TRIM26 2.5
Apoptosis
40489_AT Atrophin 1 ATN1 2.9
Other/Unknown
219301_S_AT Contactin Associated Protein-Like 2 CNTNAP2 2.8
230701_X_AT Kinesin Family Member 9 KIF9 2.9
241385_AT Dkfzp564k112 Protein LARP7 2.7
226078_AT RNA Pseudouridylate Synthase Domain Containing 1 RPUSD1 3.6
234725_S_AT Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (Tm) And Short 
Cytoplasmic Domain, (Semaphorin) 4b
SEMA4B 2.5
243768_AT Sumo1/Sentrin Specific Peptidase 6 SENP6 2.5
209253_AT Sorbin And SH3 Domain Containing 3 SORBS3 3.0
232493_AT Signal Peptidase Complex Subunit 1 Homolog (S. Cerevisiae) SPCS1 2.5
243198_AT Testis Expressed Sequence 9 TEX9 2.8
232528_AT Ubiquitin-Conjugating Enzyme E2e 3 (UBC4/5 Homolog, Yeast) UBE2E4P 2.8
240155_X_AT Zinc Finger Protein 493 ZNF493 2.5BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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in the cell is currently unknown. p30 has, however, been
documented to facilitate transcription from cellular and
viral promoters in conjunction with the transcriptional
coactivator p300/CBP [51]. Thus, similar to another
nucleolar protein, nucleolin, p30 possesses both tran-
scriptional and posttranscriptional activities. The combi-
nation of these effects likely decrease Tax and other viral
antigen expression, possibly permitting HTLV-I infected
cells to remain hidden from the immune response.
In this study, we used a genome wide analysis to investi-
gate the effect of p30 on host cell gene regulation and
found a number of cellular transcripts to be increased or
decreased (Tables 1, 2; see Additional files 1 and 2). These
genes belonged to a variety of families, including tran-
scriptional/translational control, cell cycle, DNA replica-
tion and repair, and cell signalling. While it is not yet
known whether changes in expression of any of these
genes identified here, alone or in combination, are
required for cell transformation induced by HTLV-I, some
have been shown to have altered expression patterns in
acute ATL, such as PDCD4, 90 kDa heat-shock protein,
RNA polymerase II (DNA directed), regulator of G-protein
signalling, general transcription factor IIH, and Bcl-3
[34,36,37]. Considering the possibility that p30 plays a
role in the onset of ATL in HTLV-I-infected individuals,
some of the genes regulated by p30 may be involved in the
process of cell transformation.
Using a different experimental approach which relied
upon long-term stable expression of p30 in Jurkat lym-
phocytes, it was previously shown that p30 alters the gen-
eral abundance of a number of cellular genes [23]. Several
of the transcripts shown previously to be down-regulated
were indeed seen in our array as also being negatively reg-
ulated by p30, but the difference was less than a 2.5-fold
change in expression. The differences between these
reports are not surprising given the differences in the
methodology and cell lines used for these two experi-
ments. While our study used a short-term lentiviral infec-
tion and co-transduction of peripheral blood
mononuclear cells, Michael et al. used a long-term lentivi-
ral transduction of Jurkat T-lymphocytes. It is also worth-
while to consider that long-term p30 expression has been
documented to induce cell cycle alterations, which may
also lead to different changes in gene expression [21].
Considering the differences, both studies are beneficial to
help understand the role that p30 plays in modulating
gene expression.
The main objective of this study was to evaluate whether
any cellular genes were regulated post-transcriptionally by
p30, in much the same way that p30 regulates Tax expres-
sion by preventing tax/rex mRNA export to the cytoplasm.
While it is not yet known exactly how p30 inhibits the
export of tax/rex mRNA, we hypothesized that p30 would
alter the cytoplasmic abundance of cellular transcripts. In
fact, we observed a number of cellular transcripts that
showed either a decreased or increased abundance in the
cytoplasm (Tables 3, 4). While none of these genes were
previously identified as being regulated in ATL samples,
this was to be expected since in our experimental
approach the total abundance of the genes characterized
in Tables 3 and 4 was unchanged and only cytoplasmic
abundance was affected.
So how does p30 inhibit mRNA export into the cyto-
plasm? It is possible that p30 somehow modulates the
activity of a cellular export mechanism. If this were the
case, this might explain why a variety of cellular tran-
scripts were altered in cytoplasmic abundance, indicative
of a global effect. Alternatively, p30 may bind to mRNA
transcripts to prevent their association with nuclear export
proteins, and cellular transcripts that are inhibited may
share sequence or secondary structural similarities with
the tax/rex mRNA. It has been hypothesized that p30 may
function by binding to both RNA and to Rex, another
HTLV-I protein that is conversely responsible for up-regu-
lating tax/rex mRNA export from the nucleus [20]. Indeed,
there is evidence to suggest that p30 does bind to RNA
[17,20], and that p30 might recognize a particular RNA
sequence that is present in the tax-rex message, a short 150
base pair response element present specifically at the tax/
rex splice junction [17]. Whether these interactions are
required for the inhibition of tax/rex mRNA export is not
currently known. In the current study, Rex was not
expressed, suggesting that p30 can function in the absence
of Rex. As a result, it is more likely that p30 might have a
broad mechanism of action that applies to a number of
transcripts.
On the other hand it is also possible that p30 directly or
indirectly alters regulation or function of RNA export
machinery. In this way p30 may actually only alter the
expression or export of a few genes. The altered expression
of these, in turn, might then be required for the normal
expression of remaining transcripts shown to be altered in
the presence of p30. Future work is required to examine
the effects of p30 at the level of protein expression of can-
didate proteins. Another possibility explaining the func-
tion of p30 involves the binding and alteration of known
cellular proteins involved in RNA modification and trans-
port. Again, if p30 alters a known cellular mRNA traffick-
ing pathway, it would not come as a surprise to observe so
many cellular RNA transcripts as having altered expres-
sion patterns, both in total RNA samples and in cytoplas-
mic fractions.
Following binding to RNA, p30 might then prevent the
subsequent docking and function of splicing and/orBMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
Page 11 of 14
(page number not for citation purposes)
mRNA export factors. Whether p30 recognizes the
sequence of this region or recognizes a secondary RNA
structure is not known. Indeed, such regulation has been
reported for how the retroviral HTLV Rex protein and HIV
Rev protein interact with their respective RNA binding
sites [53,54]. While there are no sequence similarities
between the Rex responsive element (RexRE) and the Rev
responsive element (RRE), HIV Rev functionally interacts
with both sites while Rex is specific for the RexRE. Com-
puter prediction of secondary structures of numerous
mRNA transcripts using specific software is not an easy
task but warrants future study.
Whether p30 interacts with RNA in a sequence-specific or
secondary structure-specific manner, there may exist sim-
ilarities between the tax/rex message and those transcripts
down-regulated in the cytoplasm (Additional file 3), and
examining these similarities will likely be the subject of
future work. In addition, such an analysis may lead to the
identification of an RNA binding motif in the p30 protein.
If such a motif were found, it could also possibly lead to
identification of therapeutic agents that could target such
a binding motif in p30. By impairing the function of p30,
one could hope to break latency and increase Tax expres-
sion in HTLV-infected patients, leading to the increased
detection of infected cells by the immune system and the
eventual clearance of infected cells from the body. This
could perhaps provide an effective therapy for HTLV-I-
infected individuals, thereby protecting patients from
developing ATL later in life.
Conclusion
In conclusion our data demonstrate that the expression of
numerous cellular genes is affected by HTLV-I p30 either
at the transcriptional or at the post-transcriptional
(nuclear export) level suggesting that p30 may alter nor-
mal cellular homeostasis and favour transformation.
Methods
Lentivirus Production and Transduction
The lentiviral HIV-based vector pHR'CMV containing
HTLV-I p30, the CMV-driven HIV helper virus deleted for
the env and nef genes(pDNL6), and the HIV long terminal
repeat-vesicular stomatitis virus G (pVSV-G) envelope
were described previously [17,55]. Semi-confluent 293 T
cells were transfected with packaging plasmid pDNL6,
pHR'CMV:myc-p30 or pHR'CMV, and pVSV-G using cal-
cium phosphate (Invitrogen) according to the manufac-
turer's instructions. At 48 hours post-transfection, cells
were washed thoroughly and co-cultured with freshly iso-
lated PBMCs. Cells were allowed to co-culture for another
48 hours, and only the non-adherent PBMCs present in
the supernatant were harvested, to separate them from
adherent 293 T producer cells. Myc-p30 expression was
evaluated by immunofluorescence. Infected suspension
cells were plated onto glass coverslips by centrifugation,
fixed with 4% paraformaldehyde, permeabilized with
0.5% Triton-X-100, and stained with anti-myc (9E10;
Santa Cruz Biotechnology), and anti-mouse-Alexa546
secondary (Molecular Probes). Cells were co-stained with
DAPI, mounted on glass slides and imaged using a Nikon
Eclipse Ti-S inverted fluorescent microscope.
To assess the rate of lentiviral infection, an assay using
GFP in place of the myc-p30 gene was used
(pHR'CMV:GFP). 293 T cells were transfected for 48 hours
and co-cultured as described above, and cells were har-
vested after 48 hours. Cells were fixed in 4% paraformal-
dehyde and analyzed for GFP expression by flow
cytometry using a FACScalibur (BD Biosciences). To deter-
mine the rate of virus production from mock producer
cells or myc-p30 lentivirus producer cells, 293 T cell
supernatants were harvested at 48 hours post transfection
and analyzed by western blotting with antisera against
HIV p24 (NIH AIDS Research and Reference Reagent Pro-
gram).
RNA Extraction and analysis
RNA from total cell extracts was isolated using Trizol (Inv-
itrogen) according to the manufacturer's instructions.
Cytoplasmic RNA was isolated by resuspending cells in a
hypotonic lysis buffer (10 mM HEPES pH7.9, 1 mM
MgCl2, 0.5 mM CaCl2, 20 mM Ribosyl complex, and
1000 U/mL of RNaseOUT (Invitrogen)), and incubated in
ice for 15 min. NP-40 was then added to a final concen-
tration of 0.27% and the lysate was immediately vortexed
for 30 seconds. Cells were centrifuged, the supernatant
(cytosolic) fraction was harvested, and proteinase K (50
ug/ml) was added and incubated at 37°C for 30 min. RNA
was extracted twice with an equal volume of chloroform,
and the final supernatant was precipitated with an equal
volume of isopropanol containing 300 mM sodium ace-
tate at -20°C. RNA samples were washed twice with 70%
ethanol, and the RNA pellet was resuspended in 100 ul
DEPC-H2O containing RNaseOUT (Invitrogen) and ribo-
syl vanadayl complex (Sigma). Samples were then treated
with DNase (10 U/ul) for 1 hour at 37°C, and extracted
with chloroform. Extracted aqueous fractions were precip-
itated with an equal volume of isopropanol overnight at -
20°C. RNA samples were centrifuged, RNA pellets were
washed twice with 70% ethanol, and resuspended in
DEPC-H2O containing RNaseOUT (Invitrogen). RNA was
quantified using a spectrophotometer and then stored at -
80°C.
To assess the purity of cytoplasmic and nuclear RNA frac-
tions, protein lysates from the cytoplasmic or nuclear frac-
tions following cytoplasmic RNA extraction were
analyzed by western blotting with anti-Cyclin A (H-432;
Santa Cruz Biotechnology) or anti-Bax (N20; Santa Cruz
Biotechnology).BMC Genomics 2009, 10:311 http://www.biomedcentral.com/1471-2164/10/311
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Microarray Analysis
RNA samples were analyzed by microarray analysis in
duplicate using an Affymetrix high-density chip, HG-
U133 (Plus-2). Microarray hybridization and detection
were performed as described in the Affymetrix GeneChip
Expression Analysis Technical Manual. Microarray data
analysis was performed according to the Affymetrix Gene-
Chip Expression Analysis (Data Analysis Fundamentals)
by the K-INBRE Bioinformatics Core (Kansas IDeA Net-
work of Biomedical Research Excellence). Minimum
information about a microarray experiment (MIAME) cri-
teria were met [56], and the complete microarray datasets
described can be found at the National Center for Biotech-
nology Information Gene Expression Omnibus http://
www.ncbi.nlm.nih.gov/geo (accession number:
GSE16098). Functional annotation of transcripts was per-
formed using the Database for Annotation, Visualization,
and Integrated Discovery (DAVID) [57].
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